Premature Ejaculation Treatment Industry Research Report 2023
Common treatment options for premature ejaculation include behavioral techniques, topical anesthetics, medications and counseling. Keep in mind that it might take time to find the treatment or combination of treatments that will work for you. Behavioral treatment plus drug therapy might be the most effective course.
Highlights
The global Premature Ejaculation Treatment market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Premature Ejaculation Treatment key players include Pfizer, Novartis, Eli Lilly, Johnson & Johnson, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Premature Ejaculation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Premature Ejaculation Treatment.
The Premature Ejaculation Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Premature Ejaculation Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Premature Ejaculation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Premature Ejaculation Treatment type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Premature Ejaculation Treatment are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Premature Ejaculation Treatment segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Premature Ejaculation Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Premature Ejaculation Treatment market.
Premature Ejaculation Treatment Segment by Distribution Channel
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Premature Ejaculation Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Premature Ejaculation Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Premature Ejaculation Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Premature Ejaculation Treatment industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Premature Ejaculation Treatment.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Premature Ejaculation Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Highlights
The global Premature Ejaculation Treatment market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Premature Ejaculation Treatment key players include Pfizer, Novartis, Eli Lilly, Johnson & Johnson, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Premature Ejaculation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Premature Ejaculation Treatment.
The Premature Ejaculation Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Premature Ejaculation Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Premature Ejaculation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Pfizer
- Novartis
- Eli Lilly
- Johnson & Johnson
- GlaxoSmithKline
- Bayer
- Menarini
- Teva
- Sunrise Pharma
- Regent Pacific
- Torrent Pharma
- Vivus
Global markets are presented by Premature Ejaculation Treatment type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Premature Ejaculation Treatment are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Premature Ejaculation Treatment segment by Type
- Antidepressants(SSRIs)
- Phosphodiesterase-5 Inhibitors
- Topical Anesthetics
- Analgesics
- Other Treatment
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Premature Ejaculation Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Premature Ejaculation Treatment market.
Premature Ejaculation Treatment Segment by Distribution Channel
- Hospital
- Retail Pharmacy
- Online Pharmacy
- Other
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Premature Ejaculation Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Premature Ejaculation Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Premature Ejaculation Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Premature Ejaculation Treatment industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Premature Ejaculation Treatment.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Premature Ejaculation Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Premature Ejaculation Treatment by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Antidepressants(SSRIs)
1.2.3 Phosphodiesterase-5 Inhibitors
1.2.4 Topical Anesthetics
1.2.5 Analgesics
1.2.6 Other Treatment
2.3 Premature Ejaculation Treatment by Distribution Channel
2.3.1 Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029)
2.3.2 Hospital
2.3.3 Retail Pharmacy
2.3.4 Online Pharmacy
2.3.5 Other
2.4 Assumptions and Limitations
3 PREMATURE EJACULATION TREATMENT BREAKDOWN DATA BY TYPE
3.1 Global Premature Ejaculation Treatment Historic Market Size by Type (2018-2023)
3.2 Global Premature Ejaculation Treatment Forecasted Market Size by Type (2023-2028)
4 PREMATURE EJACULATION TREATMENT BREAKDOWN DATA BY DISTRIBUTION CHANNEL
4.1 Global Premature Ejaculation Treatment Historic Market Size by Distribution Channel (2018-2023)
4.2 Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Premature Ejaculation Treatment Market Perspective (2018-2029)
5.2 Global Premature Ejaculation Treatment Growth Trends by Region
5.2.1 Global Premature Ejaculation Treatment Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Premature Ejaculation Treatment Historic Market Size by Region (2018-2023)
5.2.3 Premature Ejaculation Treatment Forecasted Market Size by Region (2024-2029)
5.3 Premature Ejaculation Treatment Market Dynamics
5.3.1 Premature Ejaculation Treatment Industry Trends
5.3.2 Premature Ejaculation Treatment Market Drivers
5.3.3 Premature Ejaculation Treatment Market Challenges
5.3.4 Premature Ejaculation Treatment Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Premature Ejaculation Treatment Players by Revenue
6.1.1 Global Top Premature Ejaculation Treatment Players by Revenue (2018-2023)
6.1.2 Global Premature Ejaculation Treatment Revenue Market Share by Players (2018-2023)
6.2 Global Premature Ejaculation Treatment Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Premature Ejaculation Treatment Head office and Area Served
6.4 Global Premature Ejaculation Treatment Players, Product Type & Application
6.5 Global Premature Ejaculation Treatment Players, Date of Enter into This Industry
6.6 Global Premature Ejaculation Treatment Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Premature Ejaculation Treatment Market Size (2018-2029)
7.2 North America Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Premature Ejaculation Treatment Market Size by Country (2018-2023)
7.4 North America Premature Ejaculation Treatment Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Premature Ejaculation Treatment Market Size (2018-2029)
8.2 Europe Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Premature Ejaculation Treatment Market Size by Country (2018-2023)
8.4 Europe Premature Ejaculation Treatment Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Premature Ejaculation Treatment Market Size (2018-2029)
9.2 Asia-Pacific Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Country (2018-2023)
9.4 Asia-Pacific Premature Ejaculation Treatment Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Premature Ejaculation Treatment Market Size (2018-2029)
10.2 Latin America Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Premature Ejaculation Treatment Market Size by Country (2018-2023)
10.4 Latin America Premature Ejaculation Treatment Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Premature Ejaculation Treatment Market Size (2018-2029)
11.2 Middle East & Africa Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2018-2023)
11.4 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Premature Ejaculation Treatment Introduction
11.1.4 Pfizer Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Premature Ejaculation Treatment Introduction
11.2.4 Novartis Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.2.5 Novartis Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Premature Ejaculation Treatment Introduction
11.3.4 Eli Lilly Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.3.5 Eli Lilly Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Premature Ejaculation Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Premature Ejaculation Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.5.5 GlaxoSmithKline Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Premature Ejaculation Treatment Introduction
11.6.4 Bayer Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.6.5 Bayer Recent Development
11.7 Menarini
11.7.1 Menarini Company Detail
11.7.2 Menarini Business Overview
11.7.3 Menarini Premature Ejaculation Treatment Introduction
11.7.4 Menarini Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.7.5 Menarini Recent Development
11.8 Teva
11.8.1 Teva Company Detail
11.8.2 Teva Business Overview
11.8.3 Teva Premature Ejaculation Treatment Introduction
11.8.4 Teva Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.8.5 Teva Recent Development
11.9 Sunrise Pharma
11.9.1 Sunrise Pharma Company Detail
11.9.2 Sunrise Pharma Business Overview
11.9.3 Sunrise Pharma Premature Ejaculation Treatment Introduction
11.9.4 Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.9.5 Sunrise Pharma Recent Development
11.10 Regent Pacific
11.10.1 Regent Pacific Company Detail
11.10.2 Regent Pacific Business Overview
11.10.3 Regent Pacific Premature Ejaculation Treatment Introduction
11.10.4 Regent Pacific Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.10.5 Regent Pacific Recent Development
11.11 Torrent Pharma
11.11.1 Torrent Pharma Company Detail
11.11.2 Torrent Pharma Business Overview
11.11.3 Torrent Pharma Premature Ejaculation Treatment Introduction
11.11.4 Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.11.5 Torrent Pharma Recent Development
11.12 Vivus
11.12.1 Vivus Company Detail
11.12.2 Vivus Business Overview
11.12.3 Vivus Premature Ejaculation Treatment Introduction
11.12.4 Vivus Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.12.5 Vivus Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Premature Ejaculation Treatment by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Antidepressants(SSRIs)
1.2.3 Phosphodiesterase-5 Inhibitors
1.2.4 Topical Anesthetics
1.2.5 Analgesics
1.2.6 Other Treatment
2.3 Premature Ejaculation Treatment by Distribution Channel
2.3.1 Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029)
2.3.2 Hospital
2.3.3 Retail Pharmacy
2.3.4 Online Pharmacy
2.3.5 Other
2.4 Assumptions and Limitations
3 PREMATURE EJACULATION TREATMENT BREAKDOWN DATA BY TYPE
3.1 Global Premature Ejaculation Treatment Historic Market Size by Type (2018-2023)
3.2 Global Premature Ejaculation Treatment Forecasted Market Size by Type (2023-2028)
4 PREMATURE EJACULATION TREATMENT BREAKDOWN DATA BY DISTRIBUTION CHANNEL
4.1 Global Premature Ejaculation Treatment Historic Market Size by Distribution Channel (2018-2023)
4.2 Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Premature Ejaculation Treatment Market Perspective (2018-2029)
5.2 Global Premature Ejaculation Treatment Growth Trends by Region
5.2.1 Global Premature Ejaculation Treatment Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Premature Ejaculation Treatment Historic Market Size by Region (2018-2023)
5.2.3 Premature Ejaculation Treatment Forecasted Market Size by Region (2024-2029)
5.3 Premature Ejaculation Treatment Market Dynamics
5.3.1 Premature Ejaculation Treatment Industry Trends
5.3.2 Premature Ejaculation Treatment Market Drivers
5.3.3 Premature Ejaculation Treatment Market Challenges
5.3.4 Premature Ejaculation Treatment Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Premature Ejaculation Treatment Players by Revenue
6.1.1 Global Top Premature Ejaculation Treatment Players by Revenue (2018-2023)
6.1.2 Global Premature Ejaculation Treatment Revenue Market Share by Players (2018-2023)
6.2 Global Premature Ejaculation Treatment Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Premature Ejaculation Treatment Head office and Area Served
6.4 Global Premature Ejaculation Treatment Players, Product Type & Application
6.5 Global Premature Ejaculation Treatment Players, Date of Enter into This Industry
6.6 Global Premature Ejaculation Treatment Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Premature Ejaculation Treatment Market Size (2018-2029)
7.2 North America Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Premature Ejaculation Treatment Market Size by Country (2018-2023)
7.4 North America Premature Ejaculation Treatment Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Premature Ejaculation Treatment Market Size (2018-2029)
8.2 Europe Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Premature Ejaculation Treatment Market Size by Country (2018-2023)
8.4 Europe Premature Ejaculation Treatment Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Premature Ejaculation Treatment Market Size (2018-2029)
9.2 Asia-Pacific Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Country (2018-2023)
9.4 Asia-Pacific Premature Ejaculation Treatment Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Premature Ejaculation Treatment Market Size (2018-2029)
10.2 Latin America Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Premature Ejaculation Treatment Market Size by Country (2018-2023)
10.4 Latin America Premature Ejaculation Treatment Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Premature Ejaculation Treatment Market Size (2018-2029)
11.2 Middle East & Africa Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2018-2023)
11.4 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Premature Ejaculation Treatment Introduction
11.1.4 Pfizer Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Premature Ejaculation Treatment Introduction
11.2.4 Novartis Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.2.5 Novartis Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Premature Ejaculation Treatment Introduction
11.3.4 Eli Lilly Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.3.5 Eli Lilly Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Premature Ejaculation Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Premature Ejaculation Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.5.5 GlaxoSmithKline Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Premature Ejaculation Treatment Introduction
11.6.4 Bayer Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.6.5 Bayer Recent Development
11.7 Menarini
11.7.1 Menarini Company Detail
11.7.2 Menarini Business Overview
11.7.3 Menarini Premature Ejaculation Treatment Introduction
11.7.4 Menarini Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.7.5 Menarini Recent Development
11.8 Teva
11.8.1 Teva Company Detail
11.8.2 Teva Business Overview
11.8.3 Teva Premature Ejaculation Treatment Introduction
11.8.4 Teva Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.8.5 Teva Recent Development
11.9 Sunrise Pharma
11.9.1 Sunrise Pharma Company Detail
11.9.2 Sunrise Pharma Business Overview
11.9.3 Sunrise Pharma Premature Ejaculation Treatment Introduction
11.9.4 Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.9.5 Sunrise Pharma Recent Development
11.10 Regent Pacific
11.10.1 Regent Pacific Company Detail
11.10.2 Regent Pacific Business Overview
11.10.3 Regent Pacific Premature Ejaculation Treatment Introduction
11.10.4 Regent Pacific Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.10.5 Regent Pacific Recent Development
11.11 Torrent Pharma
11.11.1 Torrent Pharma Company Detail
11.11.2 Torrent Pharma Business Overview
11.11.3 Torrent Pharma Premature Ejaculation Treatment Introduction
11.11.4 Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.11.5 Torrent Pharma Recent Development
11.12 Vivus
11.12.1 Vivus Company Detail
11.12.2 Vivus Business Overview
11.12.3 Vivus Premature Ejaculation Treatment Introduction
11.12.4 Vivus Revenue in Premature Ejaculation Treatment Business (2017-2022)
11.12.5 Vivus Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Premature Ejaculation Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Premature Ejaculation Treatment Revenue Market Share by Type (2018-2023)
Table 7. Global Premature Ejaculation Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Premature Ejaculation Treatment Revenue Market Share by Type (2024-2029)
Table 9. Global Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 10. Global Premature Ejaculation Treatment Revenue Market Share by Distribution Channel (2018-2023)
Table 11. Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 12. Global Premature Ejaculation Treatment Revenue Market Share by Distribution Channel (2024-2029)
Table 13. Global Premature Ejaculation Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Premature Ejaculation Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Premature Ejaculation Treatment Market Share by Region (2018-2023)
Table 16. Global Premature Ejaculation Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Premature Ejaculation Treatment Market Share by Region (2024-2029)
Table 18. Premature Ejaculation Treatment Market Trends
Table 19. Premature Ejaculation Treatment Market Drivers
Table 20. Premature Ejaculation Treatment Market Challenges
Table 21. Premature Ejaculation Treatment Market Restraints
Table 22. Global Top Premature Ejaculation Treatment Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Premature Ejaculation Treatment Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Premature Ejaculation Treatment Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Premature Ejaculation Treatment, Headquarters and Area Served
Table 26. Global Premature Ejaculation Treatment Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Premature Ejaculation Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Pfizer Company Detail
Table 46. Pfizer Business Overview
Table 47. Pfizer Premature Ejaculation Treatment Product
Table 48. Pfizer Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 49. Pfizer Recent Development
Table 50. Novartis Company Detail
Table 51. Novartis Business Overview
Table 52. Novartis Premature Ejaculation Treatment Product
Table 53. Novartis Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 54. Novartis Recent Development
Table 55. Eli Lilly Company Detail
Table 56. Eli Lilly Business Overview
Table 57. Eli Lilly Premature Ejaculation Treatment Product
Table 58. Eli Lilly Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 59. Eli Lilly Recent Development
Table 60. Johnson & Johnson Company Detail
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Premature Ejaculation Treatment Product
Table 63. Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. GlaxoSmithKline Company Detail
Table 66. GlaxoSmithKline Business Overview
Table 67. GlaxoSmithKline Premature Ejaculation Treatment Product
Table 68. GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 69. GlaxoSmithKline Recent Development
Table 70. Bayer Company Detail
Table 71. Bayer Business Overview
Table 72. Bayer Premature Ejaculation Treatment Product
Table 73. Bayer Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 74. Bayer Recent Development
Table 75. Menarini Company Detail
Table 76. Menarini Business Overview
Table 77. Menarini Premature Ejaculation Treatment Product
Table 78. Menarini Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 79. Menarini Recent Development
Table 80. Teva Company Detail
Table 81. Teva Business Overview
Table 82. Teva Premature Ejaculation Treatment Product
Table 83. Teva Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 84. Teva Recent Development
Table 85. Sunrise Pharma Company Detail
Table 86. Sunrise Pharma Business Overview
Table 87. Sunrise Pharma Premature Ejaculation Treatment Product
Table 88. Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 89. Sunrise Pharma Recent Development
Table 90. Regent Pacific Company Detail
Table 91. Regent Pacific Business Overview
Table 92. Regent Pacific Premature Ejaculation Treatment Product
Table 93. Regent Pacific Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 94. Regent Pacific Recent Development
Table 95. Torrent Pharma Company Detail
Table 96. Torrent Pharma Business Overview
Table 97. Torrent Pharma Premature Ejaculation TreatmentProduct
Table 98. Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 99. Torrent Pharma Recent Development
Table 100. Vivus Company Detail
Table 101. Vivus Business Overview
Table 102. Vivus Premature Ejaculation TreatmentProduct
Table 103. Vivus Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 104. Vivus Recent Development
Table 105. Pfizer Company Information
Table 106. Pfizer Business Overview
Table 107. Pfizer Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 108. Pfizer Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 109. Pfizer Recent Development
Table 110. Novartis Company Information
Table 111. Novartis Business Overview
Table 112. Novartis Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 113. Novartis Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 114. Novartis Recent Development
Table 115. Eli Lilly Company Information
Table 116. Eli Lilly Business Overview
Table 117. Eli Lilly Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 118. Eli Lilly Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 119. Eli Lilly Recent Development
Table 120. Johnson & Johnson Company Information
Table 121. Johnson & Johnson Business Overview
Table 122. Johnson & Johnson Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 123. Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 124. Johnson & Johnson Recent Development
Table 125. GlaxoSmithKline Company Information
Table 126. GlaxoSmithKline Business Overview
Table 127. GlaxoSmithKline Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 128. GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 129. GlaxoSmithKline Recent Development
Table 130. Bayer Company Information
Table 131. Bayer Business Overview
Table 132. Bayer Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 133. Bayer Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 134. Bayer Recent Development
Table 135. Menarini Company Information
Table 136. Menarini Business Overview
Table 137. Menarini Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 138. Menarini Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 139. Menarini Recent Development
Table 140. Teva Company Information
Table 141. Teva Business Overview
Table 142. Teva Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 143. Teva Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 144. Teva Recent Development
Table 145. Sunrise Pharma Company Information
Table 146. Sunrise Pharma Business Overview
Table 147. Sunrise Pharma Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 148. Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 149. Sunrise Pharma Recent Development
Table 150. Regent Pacific Company Information
Table 151. Regent Pacific Business Overview
Table 152. Regent Pacific Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 153. Regent Pacific Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 154. Regent Pacific Recent Development
Table 155. Torrent Pharma Company Information
Table 156. Torrent Pharma Business Overview
Table 157. Torrent Pharma Premature Ejaculation TreatmentRevenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 158. Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 159. Torrent Pharma Recent Development
Table 160. Vivus Company Information
Table 161. Vivus Business Overview
Table 162. Vivus Premature Ejaculation TreatmentRevenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 163. Vivus Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 164. Vivus Recent Development
Table 165. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Premature Ejaculation Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Premature Ejaculation Treatment Revenue Market Share by Type (2018-2023)
Table 7. Global Premature Ejaculation Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Premature Ejaculation Treatment Revenue Market Share by Type (2024-2029)
Table 9. Global Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 10. Global Premature Ejaculation Treatment Revenue Market Share by Distribution Channel (2018-2023)
Table 11. Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 12. Global Premature Ejaculation Treatment Revenue Market Share by Distribution Channel (2024-2029)
Table 13. Global Premature Ejaculation Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Premature Ejaculation Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Premature Ejaculation Treatment Market Share by Region (2018-2023)
Table 16. Global Premature Ejaculation Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Premature Ejaculation Treatment Market Share by Region (2024-2029)
Table 18. Premature Ejaculation Treatment Market Trends
Table 19. Premature Ejaculation Treatment Market Drivers
Table 20. Premature Ejaculation Treatment Market Challenges
Table 21. Premature Ejaculation Treatment Market Restraints
Table 22. Global Top Premature Ejaculation Treatment Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Premature Ejaculation Treatment Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Premature Ejaculation Treatment Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Premature Ejaculation Treatment, Headquarters and Area Served
Table 26. Global Premature Ejaculation Treatment Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Premature Ejaculation Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Pfizer Company Detail
Table 46. Pfizer Business Overview
Table 47. Pfizer Premature Ejaculation Treatment Product
Table 48. Pfizer Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 49. Pfizer Recent Development
Table 50. Novartis Company Detail
Table 51. Novartis Business Overview
Table 52. Novartis Premature Ejaculation Treatment Product
Table 53. Novartis Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 54. Novartis Recent Development
Table 55. Eli Lilly Company Detail
Table 56. Eli Lilly Business Overview
Table 57. Eli Lilly Premature Ejaculation Treatment Product
Table 58. Eli Lilly Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 59. Eli Lilly Recent Development
Table 60. Johnson & Johnson Company Detail
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Premature Ejaculation Treatment Product
Table 63. Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. GlaxoSmithKline Company Detail
Table 66. GlaxoSmithKline Business Overview
Table 67. GlaxoSmithKline Premature Ejaculation Treatment Product
Table 68. GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 69. GlaxoSmithKline Recent Development
Table 70. Bayer Company Detail
Table 71. Bayer Business Overview
Table 72. Bayer Premature Ejaculation Treatment Product
Table 73. Bayer Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 74. Bayer Recent Development
Table 75. Menarini Company Detail
Table 76. Menarini Business Overview
Table 77. Menarini Premature Ejaculation Treatment Product
Table 78. Menarini Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 79. Menarini Recent Development
Table 80. Teva Company Detail
Table 81. Teva Business Overview
Table 82. Teva Premature Ejaculation Treatment Product
Table 83. Teva Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 84. Teva Recent Development
Table 85. Sunrise Pharma Company Detail
Table 86. Sunrise Pharma Business Overview
Table 87. Sunrise Pharma Premature Ejaculation Treatment Product
Table 88. Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 89. Sunrise Pharma Recent Development
Table 90. Regent Pacific Company Detail
Table 91. Regent Pacific Business Overview
Table 92. Regent Pacific Premature Ejaculation Treatment Product
Table 93. Regent Pacific Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 94. Regent Pacific Recent Development
Table 95. Torrent Pharma Company Detail
Table 96. Torrent Pharma Business Overview
Table 97. Torrent Pharma Premature Ejaculation TreatmentProduct
Table 98. Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 99. Torrent Pharma Recent Development
Table 100. Vivus Company Detail
Table 101. Vivus Business Overview
Table 102. Vivus Premature Ejaculation TreatmentProduct
Table 103. Vivus Revenue in Premature Ejaculation Treatment Business (2017-2022) & (US$ Million)
Table 104. Vivus Recent Development
Table 105. Pfizer Company Information
Table 106. Pfizer Business Overview
Table 107. Pfizer Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 108. Pfizer Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 109. Pfizer Recent Development
Table 110. Novartis Company Information
Table 111. Novartis Business Overview
Table 112. Novartis Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 113. Novartis Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 114. Novartis Recent Development
Table 115. Eli Lilly Company Information
Table 116. Eli Lilly Business Overview
Table 117. Eli Lilly Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 118. Eli Lilly Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 119. Eli Lilly Recent Development
Table 120. Johnson & Johnson Company Information
Table 121. Johnson & Johnson Business Overview
Table 122. Johnson & Johnson Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 123. Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 124. Johnson & Johnson Recent Development
Table 125. GlaxoSmithKline Company Information
Table 126. GlaxoSmithKline Business Overview
Table 127. GlaxoSmithKline Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 128. GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 129. GlaxoSmithKline Recent Development
Table 130. Bayer Company Information
Table 131. Bayer Business Overview
Table 132. Bayer Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 133. Bayer Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 134. Bayer Recent Development
Table 135. Menarini Company Information
Table 136. Menarini Business Overview
Table 137. Menarini Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 138. Menarini Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 139. Menarini Recent Development
Table 140. Teva Company Information
Table 141. Teva Business Overview
Table 142. Teva Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 143. Teva Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 144. Teva Recent Development
Table 145. Sunrise Pharma Company Information
Table 146. Sunrise Pharma Business Overview
Table 147. Sunrise Pharma Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 148. Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 149. Sunrise Pharma Recent Development
Table 150. Regent Pacific Company Information
Table 151. Regent Pacific Business Overview
Table 152. Regent Pacific Premature Ejaculation Treatment Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 153. Regent Pacific Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 154. Regent Pacific Recent Development
Table 155. Torrent Pharma Company Information
Table 156. Torrent Pharma Business Overview
Table 157. Torrent Pharma Premature Ejaculation TreatmentRevenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 158. Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 159. Torrent Pharma Recent Development
Table 160. Vivus Company Information
Table 161. Vivus Business Overview
Table 162. Vivus Premature Ejaculation TreatmentRevenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 163. Vivus Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 164. Vivus Recent Development
Table 165. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Premature Ejaculation Treatment Product Picture
Figure 5. Global Premature Ejaculation Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Premature Ejaculation Treatment Market Share by Type: 2022 VS 2029
Figure 7. Antidepressants(SSRIs) Product Picture
Figure 8. Phosphodiesterase-5 Inhibitors Product Picture
Figure 9. Topical Anesthetics Product Picture
Figure 10. Analgesics Product Picture
Figure 11. Other Treatment Product Picture
Figure 12. Global Premature Ejaculation Treatment Market Size by Distribution Channel (2023-2029) & (US$ Million)
Figure 13. Global Premature Ejaculation Treatment Market Share by Distribution Channel: 2022 VS 2029
Figure 14. Hospital Product Picture
Figure 15. Retail Pharmacy Product Picture
Figure 16. Online Pharmacy Product Picture
Figure 17. Other Product Picture
Figure 18. Global Premature Ejaculation Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Premature Ejaculation Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Premature Ejaculation Treatment Market Share by Region: 2022 VS 2029
Figure 21. Global Premature Ejaculation Treatment Market Share by Players in 2022
Figure 22. Global Premature Ejaculation Treatment Players, Date of Enter into This Industry
Figure 23. Global Top 5 and 10 Premature Ejaculation Treatment Players Market Share by Revenue in 2022
Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 25. North America Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. North America Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 27. United States Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 31. Germany Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 39. China Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Japan Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 47. Mexico Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Brazil Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 51. Turkey Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. UAE Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Pfizer Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 55. Novartis Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 56. Eli Lilly Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 59. Bayer Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 60. Menarini Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 61. Teva Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 62. Sunrise Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 63. Regent Pacific Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 64. Torrent Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 65. Vivus Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Premature Ejaculation Treatment Product Picture
Figure 5. Global Premature Ejaculation Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Premature Ejaculation Treatment Market Share by Type: 2022 VS 2029
Figure 7. Antidepressants(SSRIs) Product Picture
Figure 8. Phosphodiesterase-5 Inhibitors Product Picture
Figure 9. Topical Anesthetics Product Picture
Figure 10. Analgesics Product Picture
Figure 11. Other Treatment Product Picture
Figure 12. Global Premature Ejaculation Treatment Market Size by Distribution Channel (2023-2029) & (US$ Million)
Figure 13. Global Premature Ejaculation Treatment Market Share by Distribution Channel: 2022 VS 2029
Figure 14. Hospital Product Picture
Figure 15. Retail Pharmacy Product Picture
Figure 16. Online Pharmacy Product Picture
Figure 17. Other Product Picture
Figure 18. Global Premature Ejaculation Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Premature Ejaculation Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Premature Ejaculation Treatment Market Share by Region: 2022 VS 2029
Figure 21. Global Premature Ejaculation Treatment Market Share by Players in 2022
Figure 22. Global Premature Ejaculation Treatment Players, Date of Enter into This Industry
Figure 23. Global Top 5 and 10 Premature Ejaculation Treatment Players Market Share by Revenue in 2022
Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 25. North America Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. North America Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 27. United States Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 31. Germany Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 39. China Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Japan Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 47. Mexico Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Brazil Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 51. Turkey Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. UAE Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Pfizer Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 55. Novartis Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 56. Eli Lilly Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 59. Bayer Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 60. Menarini Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 61. Teva Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 62. Sunrise Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 63. Regent Pacific Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 64. Torrent Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 65. Vivus Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
